Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.
about
Heparin and related substances for preventing diabetic kidney diseaseCausality relationships between coagulation factors in type 2 diabetes mellitus: path analysis approachHyperglycemia increases susceptibility to ischemic necrosis.High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetesThe importance of endothelin-1 for microvascular dysfunction in diabetesWhat is the role of hyperbaric oxygen in the management of diabetic foot disease?Why critical limb ischemia criteria are not applicable to diabetic foot and what the consequences are.Novel biological therapies for the treatment of diabetic foot ulcers.The wound/burn guidelines - 3: Guidelines for the diagnosis and treatment for diabetic ulcer/gangrene.Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes.Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.
P2860
Q24235372-4EF8142A-DE4E-481B-99CE-517532D7FFC9Q34451089-0EFF1499-623D-4C0D-8AB0-BF4811F73F0EQ34627320-0C2FCAF8-8399-453B-A3E8-A1E15B4F55DBQ35688330-E694D3AE-FF64-4A5C-B454-98CCD1D64487Q37381938-C3669793-3FD5-4F26-93A1-8EB45564798DQ37870863-C392692B-F01F-40A3-9B5D-1E2D29124624Q38012702-F1D83B77-47CA-44A7-97FE-D0D8F03C4EFFQ38770565-FB0D8C82-1466-4DFD-A889-5FD37671235AQ40757188-1933C66A-58D3-44B5-94F7-D5170B47779EQ41566844-AD09D71C-F843-40E2-86B1-6FBDF6E1AC2DQ46419831-5AED3EC3-723A-4BFD-94BA-4AE4BFBEAE62
P2860
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Beneficial effects of daltepar ...... cular disease and foot ulcers.
@ast
Beneficial effects of daltepar ...... cular disease and foot ulcers.
@en
Beneficial effects of daltepar ...... cular disease and foot ulcers.
@nl
type
label
Beneficial effects of daltepar ...... cular disease and foot ulcers.
@ast
Beneficial effects of daltepar ...... cular disease and foot ulcers.
@en
Beneficial effects of daltepar ...... cular disease and foot ulcers.
@nl
prefLabel
Beneficial effects of daltepar ...... cular disease and foot ulcers.
@ast
Beneficial effects of daltepar ...... cular disease and foot ulcers.
@en
Beneficial effects of daltepar ...... cular disease and foot ulcers.
@nl
P2093
P1433
P1476
Beneficial effects of daltepar ...... cular disease and foot ulcers.
@en
P2093
Angela Silveira
Bengt Fagrell
Björn Eliasson
Gun Jörneskog
Jan Apelqvist
Jan W Eriksson
Majid Kalani
Margareta Blombäck
Ole Torffvit
P304
P356
10.1016/J.THROMRES.2006.12.006
P577
2007-02-02T00:00:00Z